Encompass Health (NYSE:EHC) Downgraded to Hold Rating by Wall Street Zen

Encompass Health (NYSE:EHC) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.

EHC has been the topic of several other reports. Barclays upped their price target on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. UBS Group upped their target price on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. KeyCorp increased their price target on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Finally, Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Two research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $142.86.

Encompass Health Price Performance

NYSE:EHC opened at $102.89 on Friday. The firm has a market capitalization of $10.35 billion, a price-to-earnings ratio of 19.45, a PEG ratio of 1.69 and a beta of 0.74. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.14 and a quick ratio of 1.14. The business has a 50 day simple moving average of $110.79 and a 200-day simple moving average of $117.02. Encompass Health has a 1 year low of $90.67 and a 1 year high of $127.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.The company had revenue of $136.30 million for the quarter. Equities analysts forecast that Encompass Health will post 4.8 EPS for the current year.

Institutional Investors Weigh In On Encompass Health

Several hedge funds have recently made changes to their positions in EHC. Tectonic Advisors LLC increased its stake in shares of Encompass Health by 1.6% during the third quarter. Tectonic Advisors LLC now owns 5,337 shares of the company’s stock valued at $678,000 after buying an additional 82 shares during the period. Global Retirement Partners LLC increased its position in Encompass Health by 23.0% during the 3rd quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock valued at $57,000 after purchasing an additional 84 shares during the period. EP Wealth Advisors LLC increased its position in Encompass Health by 2.4% during the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after purchasing an additional 88 shares during the period. Natural Investments LLC lifted its position in shares of Encompass Health by 1.2% in the 3rd quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock worth $991,000 after purchasing an additional 89 shares during the period. Finally, Allworth Financial LP boosted its stake in shares of Encompass Health by 14.7% during the third quarter. Allworth Financial LP now owns 701 shares of the company’s stock valued at $89,000 after purchasing an additional 90 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.